(NP (NP (NN CTL) (NN recognition)) (PP (IN of) (NP (DT an) (JJ altered) (NN peptide))) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NN asparagine) (NN bond) (NN rearrangement)))) (. .))
(NP (NP (NNS Implications)) (PP (IN for) (NP-COOD (NP (NN immunity)) (CC and) (NP (NN vaccine) (NN design)))) (. .))
(S (NP-SBJ-46 (NP (DT The) (NN extent)) (SBAR (WHPP-47 (TO to) (WHNP (WDT which))) (S (NP-SBJ-48 (NP (NNS peptides)) (VP (VBG containing) (NP (ADJP (ADVP-COOD (ADVP (RB chemically)) (CC and) (ADVP-TMP (RB post-translationally))) (VBN modified)) (NN amino) (NN acid) (JJ side) (NNS chains)))) (VP (VBP are) (VP (VBN recognized) (NP (-NONE- *-48)) (PP (IN by) (NP-LGS (JJ primed) (NN CTL))) (PP (-NONE- *T*-47))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB clearly)) (VP (VBN defined) (NP (-NONE- *-46))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP report) (PP (IN on) (NP (NP (DT the) (NN CTL) (NN recognition)) (PP (IN of) (NP (NP (DT a) (ADJP (NN MHC) (NN class) (JJ I-restricted)) (NN peptide)) (VP (VBG containing) (NP (DT a) (NP (NP (JJ cyclized) (NN asparagine)) (PRN (-LRB- -LRB-) (NP (NN succinimide)) (-RRB- -RRB-))) (NN residue)))))))) (. .))
(S (NP-SBJ (NP (DT This) (NN modification)) (PP (IN of) (NP (DT the) (NN asparagine) (JJ side) (NN chain)))) (VP-COOD (VP (VBZ is) (NP-PRD (NP (DT a) (JJ common) (JJ intermediate) (NN structure)) (PP-TMP (IN during) (NP (NP-COOD (NP (NN deamidation)) (, ,) (NP (NN isomerization)) (, ,) (CC and) (NP (NN bond) (NNS rearrangements))) (PP (IN of) (NP (JJ amide-containing) (NN amino) (NNS acids))))))) (CC and) (RB also) (VP (VBZ occurs) (PP (IN as) (NP (NP (DT a) (JJ side) (NN reaction)) (PP (IN in) (NP (NN peptide) (NN synthesis))))))) (. .))
(S (NP-SBJ (DT The) (NN CTL)) (ADVP (RB specifically)) (VP (VBD recognized) (NP (NP (DT the) (JJ succinimide-containing) (NN peptide)) (VP (VBG showing) (NP (ADJP (RB only) (JJ weak)) (NN cross-reactivity)) (PP (IN at) (NP (NP (JJ high) (NNS concentrations)) (PP (IN of) (NP (NP (DT the) (NN parent) (NN peptide)) (VP (VBG containing) (NP (JJ unmodified) (NN asparagine)))))))))) (. .))
(S (ADVP (RB Similarly)) (, ,) (NP-SBJ (NP (NN CTL)) (VP (VBN raised) (NP (-NONE- *)) (PP (IN against) (NP (DT the) (NN parent) (NN peptide))))) (VP (VBD did) (RB not) (VP (VB recognize) (NP (NP (DT the) (JJ succinimide) (NN derivative)) (PP (IN of) (NP (DT this) (NN peptide)))))) (. .))
(S (NP-SBJ-49 (NP (ADJP (RB Naturally) (VBN processed)) (NNS forms)) (PP (IN of) (NP (DT these) (NNS structures)))) (VP (VBP are) (ADJP-PRD (JJ likely) (S (NP-SBJ (-NONE- *-49)) (VP (TO to) (VP (VB occur))))) (PP (VBN given) (NP (NP (DT the) (NP-COOD (NP (NN importance)) (CC and) (NP (NN frequency)))) (PP (IN of) (NP (NN deamidation))) (ADVP-COOD (CC both) (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (SBAR (IN since) (S (NP-SBJ (NP (NN succinimide) (NNS intermediates)) (PP (IN of) (NP (VBN deamidated) (NNS peptides)))) (VP (MD can) (ADVP-TMP (RB occasionally)) (VP (VB be) (ADJP-PRD (RB very) (JJ stable)))))) (, ,) (NP-SBJ (DT these) (NNS peptides)) (VP (VBP have) (NP (DT the) (NN potential) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB act) (PP (IN as) (NP (NP (JJ altered) (NNS self-Ags)) (PP (IN with) (NP (NP (JJ significant) (NNS implications)) (PP (IN for) (NP (NN autoimmunity)))))))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-50 (ADJP-COOD (ADJP (JJ unwanted)) (CC and) (ADJP (RB potentially) (JJ hazardous))) (NNS specificities)) (VP (MD may) (VP (VB be) (VP (VBN elicited) (NP (-NONE- *-50)) (SBAR-TMP (WHADVP-51 (WRB when)) (S (NP-SBJ (-NONE- *)) (VP (VBG using) (NP (JJ synthetic) (NNS peptides)) (PP (IN in) (NP (NP (NN subunit) (NNS vaccines)) (SBAR (WHPP-52 (IN in) (WHNP (WDT which))) (S (NP-SBJ (NN succinimide) (NNS residues)) (VP (MD may) (VP (VB form) (ADVP (RB spontaneously)) (PP-TMP (IN during) (NP-COOD (NP (NN storage)) (CC or) (NP (JJ chemical) (NN synthesis)))) (PP (-NONE- *T*-52)))))))) (ADVP (-NONE- *T*-51)))))))) (. .))
